The Daily Gazette
The Locally Owned Voice Of The Capital Region

Despite drop in royalties, AMRI happy with earnings

Text Size: A | A

Revenue dropped slightly in the first quarter of the year at Albany Molecular Research Inc., but it was still a good quarter given the greater-than-anticipated drop in royalties, the company said. The Albany-based research and manufacturing organization provides drug discovery and scientific services, technologies and products to the pharmaceutical and biotechnology industries. Its crowning achievement was the manufacture of fexofenadine, the active ingredient in the popular antihistamine drug Allegra. Its patents on this began to ...

You Must or Subscribe to Continue
subscribe to the Daily Gazette
Individual stories can be found and purchased from our Archives for $2.00

Enjoy this story? Share it!



There are currently no posts. Be the first to comment on this story.